Literature DB >> 11581402

Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivation.

Z Deng1, C J Chen, D Zerby, H J Delecluse, P M Lieberman.   

Abstract

Epstein-Barr virus (EBV) lytic cycle transcription and DNA replication require the transcriptional activation function of the viral immediate-early protein Zta. We describe a series of alanine substitution mutations in the Zta activation domain that reveal two functional motifs based on amino acid composition. Alanine substitution of single or paired hydrophobic aromatic amino acid residues resulted in modest transcription activation defects, while combining four substitutions of aromatic residues (F22/F26/W74/F75) led to more severe transcription defects. Substitution of acidic amino acid residue E27, D35, or E54 caused severe transcription defects on most viral promoters. Promoter- and cell-specific defects were observed for some substitution mutants. Aromatic residues were required for Zta interaction with TFIIA-TFIID and the CREB-binding protein (CBP) and for stimulation of CBP histone acetyltransferase activity in vitro. In contrast, acidic amino acid substitution mutants interacted with TFIIA-TFIID and CBP indistinguishably from the wild type. The nuclear domain 10 (ND10) protein SP100 was dispersed by most Zta mutants, but acidic residue mutations led to reduced, while aromatic substitution mutants led to increased SP100 nuclear staining. Acidic residue substitution mutants had more pronounced defects in transcription activation of endogenous viral genes in latently infected cells and for viral replication, as measured by the production of infectious virus. One mutant, K12/F13, was incapable of stimulating EBV lytic replication but had only modest transcription defects. These results indicate that Zta stimulates viral reactivation through two nonredundant structural motifs, one of which interacts with general transcription factors and coactivators, and the other has an essential but as yet not understood function in lytic transcription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581402      PMCID: PMC114608          DOI: 10.1128/JVI.75.21.10334-10347.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

Review 2.  Transcriptional activation: risky business.

Authors:  W P Tansey
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

3.  Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.

Authors:  P Bell; P M Lieberman; G G Maul
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator.

Authors:  R T Sarisky; Z Gao; P M Lieberman; E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

Authors:  J S Greenspan; D Greenspan; E T Lennette; D I Abrams; M A Conant; V Petersen; U K Freese
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

6.  Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.

Authors:  A L Adamson; S Kenney
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

8.  Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators.

Authors:  C J Chen; Z Deng; A Y Kim; G A Blobel; P M Lieberman
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

9.  Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma.

Authors:  R Dardari; M Khyatti; A Benider; H Jouhadi; A Kahlain; C Cochet; A Mansouri; B El Gueddari; A Benslimane; I Joab
Journal:  Int J Cancer       Date:  2000-04-01       Impact factor: 7.396

10.  Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.

Authors:  A Chevallier-Greco; E Manet; P Chavrier; C Mosnier; J Daillie; A Sergeant
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

View more
  22 in total

1.  The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation.

Authors:  Zhong Deng; Chi-Ju Chen; Michaela Chamberlin; Fang Lu; Gerd A Blobel; David Speicher; Lisa Ann Cirillo; Kenneth S Zaret; Paul M Lieberman
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

2.  Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus.

Authors:  Nadezhda Tikhmyanova; David C Schultz; Theresa Lee; Joseph M Salvino; Paul M Lieberman
Journal:  ACS Chem Biol       Date:  2014-02-19       Impact factor: 5.100

3.  Multivalent sequence recognition by Epstein-Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain.

Authors:  Pu Wang; Latasha Day; Paul M Lieberman
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

4.  The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor.

Authors:  Gangling Liao; Jian Huang; Elizabeth D Fixman; S Diane Hayward
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  TFIIA plays a role in the response to oxidative stress.

Authors:  Susan M Kraemer; David A Goldstrohm; Ann Berger; Susan Hankey; Sherry A Rovinsky; W Scott Moye-Rowley; Laurie A Stargell
Journal:  Eukaryot Cell       Date:  2006-07

6.  Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.

Authors:  Jill K Countryman; Lyndle Gradoville; George Miller
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

7.  Identification of a transcriptional activation domain in yeast repressor activator protein 1 (Rap1) using an altered DNA-binding specificity variant.

Authors:  Amanda N Johnson; P Anthony Weil
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

8.  A Noncanonical Basic Motif of Epstein-Barr Virus ZEBRA Protein Facilitates Recognition of Methylated DNA, High-Affinity DNA Binding, and Lytic Activation.

Authors:  Erin Weber; Olga Buzovetsky; Lee Heston; Kuan-Ping Yu; Kirsten M Knecht; Ayman El-Guindy; George Miller; Yong Xiong
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

9.  The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms.

Authors:  Amy Mauser; Shin'ichi Saito; Ettore Appella; Carl W Anderson; William T Seaman; Shannon Kenney
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

10.  Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function.

Authors:  Lee-Wen Chen; Vineetha Raghavan; Pey-Jium Chang; Duane Shedd; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  Virology       Date:  2009-02-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.